Venrock Adviser, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$2.68B
Q ending 2026-03-31
Prior quarter
$2.02B
Q ending 2025-12-31
Change
+32.3% QoQ · +128.0% YoY
Positions
33
reported holdings
Largest positions
All 33 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Apogee Therapeutics Inc | APGE | Shares | $714.9M | 8.5M |
| Erasca Inc | ERAS | Shares | $265.1M | 16.4M |
| Oruka Therapeutics Inc | ORKA | Shares | $203.5M | 4.1M |
| Spyre Therapeutics Inc | SYRE | Shares | $185.9M | 3.7M |
| Kalvista Pharmaceuticals Inc | 4XC1 | Shares | $130.3M | 6.5M |
| Dianthus Therapeutics Inc | DNTH | Shares | $99.0M | 1.2M |
| Damora Therapeutics Inc | DMRA | Shares | $93.3M | 3.6M |
| Ocular Therapeutix Inc | OCUL | Shares | $87.6M | 10.3M |
| Cogent Biosciences Inc | COGT | Shares | $77.0M | 2.0M |
| Viridian Therapeutics Inc | VRDN | Shares | $75.9M | 3.9M |
| Savara Inc | SVRA | Shares | $75.0M | 13.7M |
| Enliven Therapeutics Inc | ELVN | Shares | $67.7M | 1.7M |
| Oric Pharmaceuticals Inc | ORIC | Shares | $54.7M | 4.3M |
| Vor Biopharma Inc | VOR | Shares | $54.3M | 3.0M |
| Maze Therapeutics Inc | MAZE | Shares | $47.8M | 1.6M |
| Cytomx Therapeutics Inc | CTMX | Shares | $46.9M | 10.0M |
| Jade Biosciences Inc | JBIO | Shares | $45.2M | 3.2M |
| Dyne Therapeutics Inc | DYN | Shares | $39.4M | 2.2M |
| Crescent Biopharma Inc. | Shares | $39.2M | 2.1M | |
| Zura Bio Ltd | Shares | $38.3M | 6.4M | |
| Relmada Therapeutics Inc | RLMD | Shares | $33.7M | 4.8M |
| Engene Holdings Inc | Shares | $32.5M | 4.8M | |
| Tenax Therapeutics Inc | TENX | Shares | $26.8M | 1.7M |
| Adlai Nortye Ltd | ANL | Shares | $22.2M | 3.2M |
| Century Therapeutics Inc | IPSC | Shares | $19.7M | 8.7M |
| Cullinan Therapeutics Inc | CGEM | Shares | $19.6M | 1.4M |
| Cybin Inc | HELP | Shares | $18.5M | 3.9M |
| Surrozen Inc | SRZN | Shares | $18.4M | 633K |
| Septerna Inc | SEPN | Shares | $12.2M | 506K |
| Korro Bio Inc | KRRO | Shares | $11.4M | 1.0M |
| Alto Neuroscience Inc | ANRO | Shares | $11.2M | 500K |
| Artiva Biotherapeutics Inc | ARTV | Shares | $10.4M | 1.6M |
| X4 Pharmaceuticals Inc | XFOR | Shares | $1.4M | 331K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.